Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angeles A. Secord, MD
Duke Cancer Institute
Study Chair - Deborah K. Armstrong, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Nita Maihle, PhD
Yale University
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Australia New Zealand Gynaecological Oncology Trials Group
Camperdown, New South Wales, Australia
- Tom Baker Cancer Centre - Calgary
Calgary, Alberta, Canada
- Kagoshima City Hospital
Kagoshima, Japan
- Norwegian Radium Hospital
Oslo, Norway
- Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, United States
- Ccop - Western Regional, Arizona
Phoenix, Arizona, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Women'S Cancer Center - Los Gatos
Los Gatos, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
- Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
- Mbccop - Hawaii
Honolulu, Hawaii, United States
- Mbccop - University of Illinois at Chicago
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Facility name not stated
Hinsdale, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Saint Joseph Regional Medical Center
South Bend, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
- Tufts - New England Medical Center
Boston, Massachusetts, United States
- Umass Memorial Cancer Center - University Campus
Worcester, Massachusetts, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Keesler Medical Center - Keesler Air Force Base
Keesler Air Force Base, Mississippi, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish Hospital
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2004
- Primary completion
- 30 Apr 2006
- Completion
- —
- Last update posted
- 14 Feb 2014
- Registered enrollment
- —
- Registry id
- NCT00086892
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.